John M. Leonard

This profile gathers the share dealings of John M. Leonard across 3 companies, led by Intellia Therapeutics, Inc., Iqvia Holdings Inc. and Chimerix Inc. The record holds 119 filings, for trades running from 5 May 2016 to 21 August 2026.

Every open-market trade on record is a sale: 62 sales worth €49.2M. Besides market trades, the filings include 18 share grants and 39 option exercises. In 2026 alone, the filings show no purchases and 3 sales.

The newest entry dates from 24 August 2026: an open-market sale of €215k, in Intellia Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.